Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
Space Force Charts Shift to Warfighting Force for 2040
Officials outlined how new missions, resilient satellites, maneuver and AI are shaping the service’s future force.
3m read -
SSA Targets Growing Threat of AI-Enabled Fraud
SSA is strengthening federal coordination, AI tools and workforce training to detect and prevent increasingly sophisticated fraud schemes.
3m read -
AI Forces a Rethink of Federal Contracting Models
Federal acquisition leaders are examining how contracts, labor categories and pricing models evolve as AI changes technology delivery.
5m read -
New CDM Security Service Aims to Cut Cyber Response Times
CISA’s SIEM-as-a-Service platform gives federal agencies automated tools to improve threat hunting, logging and incident response.
3m read
